2024-10-22 AEWIN Tech. HaiPress
TAIPEI,Oct. 21,2024 -- AEWIN Technologies Co.,Ltd (doing business as AEWIN),a leading provider of advanced network appliances and edge computing solutions,is excited to present innovative two-phase immersion cooling (2PIC) solutions at SC24 from November 19th to 21st. Alongside versatile server platforms,AEWIN offers up-to-date thermal solutions to meet compute-intensive demands of Edge AI and green revolution.

AEWIN Presents Innovative Two-Phase Immersion Cooling Solutions
The exponential growth of data and Edge AI complexity requires more on-premises computing. To deal with the increased power consumption of CPU/GPU in edge servers,AEWIN cooperated with AMD,ITRI,KENMEC,and I-CHIUN to support up to 12U/3N with Max. 30kW cooling capacity. Featuring multiple patents for high efficiency and sustainability,it targets power usage effectiveness as low as PUE 1.02 to reduce energy and cost for thermal management.
Along with patented real-time AI CDU controller and vapor recycle system to smartly optimize the efficiency of heat dissipation,the solution supports PFAS and PFAS-free coolant to realize the sustainable value of ESG. Integrating with AEWIN server boards with the latest server grade CPUs supports,customers are free to select suitable computing power per use cases with optimized cooling solutions.
Up to 10 PCIe Gen5 accelerators per 2U server,AEWIN two-phase immersion cooling solution helps enterprises to fulfill high-density AI workloads and significantly reduce the energy consumption of heat dissipation. In addition,the system supports individual server maintenance with no need for full system shutdown to lower the Operating Expense.
Don't hesitate to join us at SC24 or contact our sales for more information at any time!
http://www.aewin.com/
CGTN: How China embraces the world with open arms, boosts development for all
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
©copyright 2009-2020 Singapore Info Map